drug · protein
patient view →sotatercept
Marketedupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 9 investigational indications.
targets
Inhibin beta A chain
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that